infective endocarditis esc 09 (2)
DESCRIPTION
all about infective endocarditisTRANSCRIPT
Infective endocarditis
Diagnosis & treatment
Cholid Tri Tjahjono, dr. SpJP
roadmap
1.1. DefinitionsDefinitions, general information, general information
2. Clinical symptoms
3. Diagnosis
1. Duke criteria
2. Blood cultures
3. Echocardiography
4. Treatment basics
5. Complications
6. Prophylaxis
7. Summary
Definitions, general information
Infective endocarditis Infective endocarditis
inflammatory process on-going inside endocardium
due to infection after endothelium damage
most often involving aortic and mitral valves
Definitions, general information - continuedAcording to localisation Acording to localisation
Left sided IE
Native valve IE (NVE)
Prosthetic valve IE(PVE)
Early < 1 year after surgery
Late >1 year after surgery
Right sided IE
Device- related IE (ICD)
Definitions, general information - continued
AAcording to the mode of acquisitioncording to the mode of acquisition
Health-care associated IE
Nosocomial
Non-nosocomial
Community acquired IE
Intravenous drug abuse-associated IE
Definitions, general information- continued
Active IE
Recurrence
Relpse
Reinfection
Definitions, general information- continued 3-10/100 000/year
Maximum at the age of 70-80
More common in women
Staphylococcus aureus is the most common pathogen
Streptococcal IE is still the most common in developing countries
roadmap
1. Definitions, general information
2.2. Clinical symptomsClinical symptoms
3. Diagnosis
1. Duke criteria
2. Blood cultures
3. Echocardiography
4. Treatment basics
5. Complications
6. Prophylaxis
7. Summary
Clinical symptoms
Fever – over 90% of patients
New intra-cardiac murmur - about 85% of patients
Roth spots, petechiae, glomerulonephritis – up to 30% of patients
Clinical symptoms – when to suspect?
Sepsis of unknown origin
Fever coexsisting with: Intracardiac implantable material
IE history
Congenital heart disease or valve disease
IE risk factors
Congestive heart failure symptoms
New heart block
Positive blood cultures
Focal neurological signs without known aetiology
Periferal abscesess (kidney, spleen, brain, vertebral column)
roadmap
1. Definitions
2. Clinical symptoms
3. Diagnosis
1.1. Duke criteriaDuke criteria
2. Blood cultures
3. Echocardiography
4. Treatment basics
5. Complications
6. Prophylaxis
7. Summary
Duke criteria
Major criteria1. Blood culture positive for
typical IE-causing microorganism
2. Evidence of endocardial involvement
Minor criteria1. Predisposition – heart
condition or i.v. drug abuse
2. Fever – temp. >38 °C
3. Vascular phenomena – arterial emboli etc.
4. Immunologic phenomena – glomerulonephritis, Osler’s nodes, Roth’s spots
5. Microbiological evidence – positive blood cultures but do not meet major criteria
Diagnosis• 2 major criteria• 1 major and 3 minor• 5 minor criteria
roadmap
1. Definitions
2. Clinical symptoms
3. Diagnosis
1. Duke criteria
2.2. Blood culturesBlood cultures
3. Echocardiography
4. Treatment basics
5. Complications
6. Prophylaxis
7. Summary
Blood cultures
Always before starting antibiotics
Always triple samples – aerobe, anaerobe and mycotic , 10 ml each
Three sets of samples required
roadmap
1. Definitions
2. Clinical symptoms
3. Diagnosis
1. Duke criteria
2. Blood cultures
3.3. EchocardiographyEchocardiography
4. Treatment basics
5. Complications
6. Prophylaxis
7. Summary
Echocardiography
Transthoracic (TTE) and transoesophageal (TEE)
fundamental importance in diagnosis, management, and follow-up
Should be performed as soon as the IE is suspected
Sensitivity of TEE is bigger than TTE (vs 90-100% vs. 40-63% )
TEE is first choice to find IE complications
Echocardiography
Echocardiographic findings in IEEchocardiographic findings in IE
Vegetation
Abscess
Pseudoaneurysm
Perforation
Fistula
Valve aneurysm
Dishence of prosthetic valve
roadmap
1. Definitions
2. Clinical symptoms
3. Diagnosis
1. Duke criteria
2. Blood cultures
3. Echocardiography
4.4. Treatment basicsTreatment basics
5. Complications
6. Prophylaxis
7. Summary
Treatment basics
Sucess relies on eradication of pathogen
Bactericidal regiment should be used
Drug choice due to pathogen
Surgery is used mainly to cope with structural complications
Treatment basics - continued
NVE standard therapy - it takes 2-6 weeks to eradicate the pathogen
PVE – longer regime is necessery – over 6 weeks
In Streptococcal IE shorter, 2 week course, can be used when combining β-laktams with aminoglycosides
Most widely used drugs – amoxycylin, gentamycin
In case of β-laktams alergy - vancomycin
roadmap
1. Definitions
2. Clinical symptoms
3. Diagnosis
1. Duke criteria
2. Blood cultures
3. Echocardiography
4. Treatment basics
5.5. ComplicationsComplications
6. Prophylaxis
7. Summary
Complications
1.1. Congestive heart failureCongestive heart failure
• Most common complication
• Main indication to surgical treatment
• ~60% of IE patients
2.2. Uncontrolled infectionUncontrolled infection
• Persisting infection
• Perivalvular extension in infective endocarditis
3.3. Systemic embolismSystemic embolism
• Brain, spleen and lungs
• 30% of IE patients
• May be the first symptom
Complications - continued
5.5. Neurologic eventsNeurologic events
6.6. Acute renal failureAcute renal failure
7.7. Rheumatic problemsRheumatic problems
8.8. MyocarditisMyocarditis
roadmap
1. Definitions
2. Clinical symptoms
3. Diagnosis
1. Duke criteria
2. Blood cultures
3. Echocardiography
4. Treatment basics
5. Complications
6.6. ProphylaxisProphylaxis
7. Summary
Prophylaxis
First and most important – proper oral hygieneproper oral hygiene
Regular Regular dental reviewdental review
Antibiotics only in high-risk group patients
Prosthetic valve or foreign material used for heart repair
History of IE
Congenital heart disease
Cyanotic without correction or with residual lickeage
CHD without lickeage but up to 6 months after surgery
Use amoxycilin or ampicylin 30-60 min prior to intervention
roadmap
1. Definitions
2. Clinical symptoms
3. Diagnosis
1. Duke criteria
2. Blood cultures
3. Echocardiography
4. Treatment basics
5. Complications
6. Prophylaxis
7.7. SummarySummary
Summary
1. IE is rare but serious disease, with high mortality rate
2. Every case of fever of unknown origin should be suspected for IE
3. Blood cultures are essential for diagnosis
4. TTE/TEE is the best method to monitor and follow-up of IE
5. Antibiotics are main treatment
6. CHF is the most common complication
7. Pharmacological prophylaxis is reserved for a narrow group of high risk patients